TREATMENT OF PSEUDOMONAS AND SERRATIA INFECTIONS WITH CEFTAZIDIME

被引:2
作者
BERGIN, CJ
PHILLIPS, P
CHAN, RMT
RUEDY, J
CRICHTON, EP
机构
[1] ST PAULS HOSP,DEPT MED,VANCOUVER V6Z 1Y6,BC,CANADA
[2] ST PAULS HOSP,DEPT LABS,VANCOUVER V6Z 1Y6,BC,CANADA
关键词
D O I
10.1093/jac/15.5.613
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:613 / 621
页数:9
相关论文
共 12 条
[1]   THE INVITRO ACTIVITY OF CEFTAZIDIME COMPARED WITH THAT OF OTHER CEPHALOSPORINS [J].
BINT, AJ ;
YEOMAN, P ;
KILBURN, P ;
ANDERSON, R ;
STANSFIELD, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :47-51
[2]   PRE-CLINICAL SAFETY EVALUATION OF CEFTAZIDIME [J].
CAPELEDWARDS, K ;
LOSTY, CR ;
TUCKER, ML ;
PRATT, DAH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :237-239
[3]   COMPARATIVE INVITRO ACTIVITY OF CEFTAZIDIME (GR-20263) AND OTHER BETA-LACTAMASE STABLE CEPHALOSPORINS AGAINST ANAEROBIC-BACTERIA [J].
CHOW, AW ;
BARTLETT, KH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :91-95
[4]   CLINICAL-EXPERIENCE WITH CEFTAZIDIME FOR LOWER RESPIRATORY-TRACT INFECTIONS [J].
DESANDRE, G ;
CORROCHER, R ;
GABRIELLI, GB ;
HO, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :307-310
[5]  
GORDTS B, 1982, LANCET, V1, P1355
[6]   PHARMACOKINETICS OF CEFTAZIDIME IN NORMAL SUBJECTS [J].
HARDING, SM ;
AYRTON, J ;
THORNTON, JE ;
MUNRO, AJ ;
HOGG, MIJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :261-261
[7]   CEFTAZIDIME - INVITRO ANTIBACTERIAL ACTIVITY AND SUSCEPTIBILITY TO BETA-LACTAMASES COMPARED WITH THAT OF CEFOTAXIME, MOXALACTAM AND OTHER BETA-LACTAM ANTIBIOTICS [J].
PHILLIPS, I ;
WARREN, C ;
SHANNON, K ;
KING, A ;
HANSLO, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :23-31
[8]  
SANDERS WE, 1974, NEW ENGLAND J MED, V90, P424
[9]   CHANGING PATTERNS OF HOSPITAL INFECTIONS AND ANTIBIOTIC USE - PREVALENCE SURVEYS IN A COMMUNITY-HOSPITAL [J].
STEVENS, GP ;
JACOBSON, JA ;
BURKE, JP .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (05) :587-592
[10]   NOSOCOMIAL INFECTION OF THE URINARY-TRACT [J].
TURCK, M ;
STAMM, W .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (03) :651-654